ezetimibe has been researched along with Cirrhosis, Liver in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, JH; Chang, Y; Jang, JY; Jeong, SW; Kim, HS; Kim, SG; Kim, YS; Lee, SH; Lee, WM; Moon, JE; Yoo, JJ | 1 |
| Abbas, M; Abbas, Z; Asim, M; Saad, M; Samejo, SA | 1 |
| Blazing, M; Cannon, CP; Chung, RT; Corey, KE; Giugliano, RP; O'Donoghue, ML; Park, JG; Simon, TG | 1 |
| Pitha, J | 1 |
| Fujita, K; Inamori, M; Kirikoshi, H; Kubota, K; Masaki, N; Mizoue, T; Nagashima, Y; Nakajima, A; Nozaki, Y; Saito, S; Shinohara, Y; Takahashi, H; Terauchi, Y; Wada, K; Yoneda, M | 1 |
| Fukui, M; Hasegawa, G; Itoh, Y; Minami, M; Mitsuyoshi, H; Nakamura, N; Obayashi, H; Ohta, M; Okanoue, T; Park, H; Shima, T; Yamaguchi, K; Yasui, K; Yoshikawa, T | 1 |
| Cook, J; Davis, H; Hoos, L; Hwa, JJ; Tetzloff, G; van Heek, M; Zheng, S | 1 |
4 trial(s) available for ezetimibe and Cirrhosis, Liver
| Article | Year |
|---|---|
Effect of Nutrition Education in NAFLD Patients Undergoing Simultaneous Hyperlipidemia Pharmacotherapy: A Randomized Controlled Trial.
Topics: Adult; Alanine Transaminase; Ezetimibe; Female; Health Education; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Nutrition Therapy; Nutritional Sciences; Prospective Studies; Republic of Korea | 2021 |
The effect of twelve weeks of treatment with ezetimibe on HDV RNA level in patients with chronic hepatitis D.
Topics: Adult; Antiviral Agents; Ezetimibe; Female; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Liver Cirrhosis; Male; Middle Aged; Organic Anion Transporters, Sodium-Dependent; Proof of Concept Study; RNA, Viral; Symporters; Treatment Outcome; Viral Load; Young Adult | 2020 |
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe.
Topics: Aged; Anticholesteremic Agents; Cardiovascular Diseases; Ezetimibe; Female; Humans; Internationality; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Prospective Studies; Risk Factors; Secondary Prevention; Severity of Illness Index | 2018 |
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.
Topics: Adult; Anticholesteremic Agents; Azetidines; Biomarkers; Biopsy; Drug Administration Schedule; Ezetimibe; Fatty Liver; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Treatment Outcome | 2011 |
3 other study(ies) available for ezetimibe and Cirrhosis, Liver
| Article | Year |
|---|---|
Improved management of patients after acute coronary syndrome: using nonalcoholic fatty liver disease fibrosis score and ezetimibe?
Topics: Acute Coronary Syndrome; Azetidines; Ezetimibe; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease | 2018 |
Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease.
Topics: Acarbose; Animals; Anticholesteremic Agents; Azetidines; Carrier Proteins; Cholesterol; Dietary Fats; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Ezetimibe; Fatty Liver; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; PPAR alpha; Receptors, LDL; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2009 |
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Topics: Alanine Transaminase; Animals; Anticholesteremic Agents; Azetidines; Cholesterol Esters; Cholesterol, Dietary; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Ezetimibe; Fatty Liver; Hepatomegaly; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Obesity; Time Factors; Triglycerides | 2008 |